DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
- Description:
Fluorescent adenosine receptor agonist
- Description:
Competitive fluorescent adenosine receptor antagonist
- Description:
Fluorescent A3 adenosine receptor antagonist
- Description:
Fluorescent β2 adrenoceptor antagonist
- Description:
Competitive fluorescent β2-adrenoceptor antagonist
- Description:
Fluorescent β2-adrenoceptor antagonist
- Description:
Fluorescent D1 dopamine receptor antagonist
- Description:
Fluorescent H1 histamine receptor antagonist
- Description:
Fluorescent H2 histamine receptor antagonist